Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness studyAkiko Kowada
5 November 2024
Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessionsSara Aldallal, Mohamed Farghaly, Sahar Fahmy, Khalid A Alnaqbi, Wael Al Naeem, Mouza Alsaadi, Marleine Moukarzel, Ahmad Nader Fasseeh, Nada Korra, Sherif Abaza, Zoltán Kaló
4 November 2024
Evaluating the social return on investment of dance movement for wellbeing in the prevention of burnout among healthcare staff: a study protocolMary Lynch, Teresa Filipponi, Carolyn Wallace
2 November 2024
Patients’ perspectives on ethical principles to fairly allocate scarce surgical resources during the COVID-19 pandemic in the Netherlands: a Q-methodology studyAnouk van Alphen, Caroline Lekkerkerker, Job van Exel, Rob Baatenburg de Jong, Kees Ahaus
23 September 2024
Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trialBelinda Daniel, David E Lawrence, Benjamin S McKenna, Phillip Saccone, Thomas McRae, A Eden Evins, Robert M Anthenelli
20 September 2024
Stated preferences of adolescents and young adults for sexual and reproductive health services in Africa: a systematic review protocolMelaku Birhanu Alemu, Richard Norman, Jaya Dantas, Daniel Gashaneh Belay, Gavin Pereira, Gizachew A Tessema
10 September 2024
Cost-effectiveness analysis of app-delivered self-management support (selfBACK) in addition to usual care for people with low back pain in DenmarkLine Planck Kongstad, Cecilie Krage Øverås, Christian Volmar Skovsgaard, Louise Fleng Sandal, Jan Hartvigsen, Karen Søgaard, Paul Jarle Mork, Mette Jensen Stochkendahl
5 September 2024
Impact of perioperative diagnostic tools on clinical outcomes and cost-effectiveness in parathyroid surgery: a decision model-based analysisDaniel Bátora, Rowan Iskandar, Juerg Gertsch, Reto M Kaderli
5 September 2024
Cost-effectiveness of consolidation durvalumab for inoperable stage III non-small cell lung cancer in VietnamVu Quynh Mai, Lars Lindholm, Hoang Van Minh, Sun Sun, Kim Bao Giang, Klas-Göran Sahlén
30 August 2024
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic modelWenqianzi Yang, Xuemei Zhen, Xueshan Sun, Shikha Upadhyaya Khatiwada, Danhong Yang, Yixi Chen, Peng Dong, Amer Al-Taie, Jason Gordon, Hengjin Dong
29 August 2024
